Metalloproteinase 9 as a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab

被引：1
|
作者：
Zahednasab, Hamid [1 ]
Harirchian, Mohammad Hossein [2 ]
Karampoor, Sajad [3 ]
Keyvani, Hossein [3 ]
机构：
[1] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[2] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurol, Iranian Ctr Neurol Res, Tehran, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Virol, Tehran, Iran
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷 / 04期
关键词：
D O I：
10.1002/ana.25037
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：647 / 647
页数：1
相关论文
共 50 条
  • [21] Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis
    Faulkner, Michele
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1737 - 1748
  • [22] Progressive multifocal leukoencephalopathy and natalizumab
    Hellwig, Kerstin
    Gold, Ralf
    JOURNAL OF NEUROLOGY, 2011, 258 (11) : 1920 - 1928
  • [23] Natalizumab and Progressive Multifocal Leukoencephalopathy
    Warnke, Clemens
    Menge, Til
    Hartung, Hans-Peter
    Racke, Michael K.
    Cravens, Petra D.
    Bennett, Jeffrey L.
    Frohman, Elliot M.
    Greenberg, Benjamin M.
    Zamvil, Scott S.
    Gold, Ralf
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Stuve, Olaf
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 923 - 930
  • [24] Natalizumab and progressive multifocal leukoencephalopathy
    Adelman, B
    Sandrock, A
    Panzara, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04): : 432 - 433
  • [25] Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis
    Joshua J. Chalkley
    Joseph R. Berger
    Current Neurology and Neuroscience Reports, 2013, 13
  • [26] Progressive multifocal leukoencephalopathy and natalizumab
    Kerstin Hellwig
    Ralf Gold
    Journal of Neurology, 2011, 258 : 1920 - 1928
  • [27] Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis
    Chalkley, Joshua J.
    Berger, Joseph R.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (12)
  • [28] Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy
    Serana, Federico
    Chiarini, Marco
    Sottini, Alessandra
    Bertoli, Diego
    Giustini, Viviana
    Tessitore, Marion Vaglio
    Caimi, Luigi
    Capra, Ruggero
    Imberti, Luisa
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 277 (1-2) : 6 - 12
  • [29] Assessing understanding of individual risk and symptoms of progressive multifocal leukoencephalopathy in patients prescribed natalizumab for multiple sclerosis
    Rath, Louise
    Vijiaratnam, Nirosen
    Skibina, Olga
    INTERNAL MEDICINE JOURNAL, 2017, 47 (02) : 194 - 199
  • [30] Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients
    Dalla Costa, Gloria
    Martinelli, Vittorio
    Moiola, Lucia
    Sangalli, Francesca
    Colombo, Bruno
    Finardi, Annamaria
    Cinque, Paola
    Kolb, Eva-Maria
    Haghikia, Aiden
    Gold, Ralf
    Furlan, Roberto
    Comi, Giancarlo
    ANNALS OF NEUROLOGY, 2019, 85 (04) : 606 - 610
12345